KOD
Kodiak Sciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$91.35
+6.53%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-396.1%
Return on equity
-94.2%
Return on assets
-157.2%
Return on invested capital
0.00x
Asset turnover
-$158.5M
Cash from operations
$2.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026